FDA-Approved Q-Pad Test System Uses Menstrual Blood to Measure HbA1c
The FDA has cleared the Q-Pad and A1c Test to measure HbA1c in diabetic patients via at-home collection of menstrual blood samples.
Stay updated with breaking news from Test System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA has cleared the Q-Pad and A1c Test to measure HbA1c in diabetic patients via at-home collection of menstrual blood samples.
The FDA has cleared the Q-Pad and A1c Test to measure HbA1c in diabetic patients via at-home collection of menstrual blood samples.
Point-of-Care Opioid Testing MarketThe point-of-care opioid testing market is anticipated to reach a valuation of US$ 450.9 million by 2023. The market is anticipated to grow at a 4.9% CAGR over the course of the forecast period, reaching US$ 725.1 million by 2033. The growing opioid epidemic, growing public awarene...
Electric vehicles are undoubtedly a great alternative for the future. These three EV stocks look to have a bright future.
SerialTek Announces PCIe 6.0 / CXL 3.0 Protocol Test System With Industry’s ...